Tyra Biosciences, Inc. (TYRA)
↓ Download CSVKey ratios (FY2025)
-46.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$132.76M | -$104.18M | -$79.94M | -$58.93M | -$26.29M | -$9.30M | — |
| Net Income | -$119.95M | -$86.48M | -$69.13M | -$55.33M | -$26.29M | -$9.34M | — |
| EPS (Diluted) | $-2.01 | $-1.51 | $-1.62 | $-1.32 | $-1.91 | — | — |
| Total Assets | $282.61M | $363.56M | $225.86M | $266.18M | $306.70M | $16.01M | — |
| Total Liabilities | $23.43M | $20.41M | $21.59M | $8.35M | $4.96M | $2.00M | — |
| Shareholders' Equity | $259.18M | $343.15M | $204.26M | $257.83M | $301.74M | -$13.64M | -$4.74M |
| Cash & Equivalents | $77.39M | $91.97M | $58.01M | $251.21M | $302.18M | $15.22M | — |
| Operating Cash Flow | -$95.14M | -$69.77M | -$50.14M | -$50.28M | -$23.75M | -$7.76M | — |
| Capital Expenditures | $141.0K | $664.0K | $770.0K | $559.0K | $661.0K | $312.0K | — |
| Shares Outstanding | 53.71M | 50.75M | 43.02M | 42.35M | 41.44M | 1.83M | — |